Shapes of MHC Restriction Review

Total Page:16

File Type:pdf, Size:1020Kb

Shapes of MHC Restriction Review Immunity, Vol. 10, 1±7, January, 1999, Copyright 1999 by Cell Press Shapes of MHC Restriction Review David N. Garboczi*³ and William E. Biddison²³ structures of a TCR b subunit and a Va domain con- *Structural Biology Section firmed predictions that the TCR V and C domains are National Institute of Allergy and Infectious Diseases very similar to the corresponding structures observed National Institutes of Health in antibody molecules (Bentley and Mariuzza, 1996). Rockville, Maryland 20852±1727 Each of the three CDR loops protrude from the same ² Molecular Immunology Section face of the molecule. A fourth loop, termed HV4, is also Neuroimmunology Branch present. The exception to these similarities has been National Institute of Neurological Disorders the C domain of the a chain that has a noncanonical and Stroke fold (Garcia et al., 1996; Ding et al., 1998). Structural National Institutes of Health studies of entire abTCR molecules were slowed by the Bethesda, Maryland 20892 the inability to produce sufficient amounts of TCR pro- tein to analyze, but in the last three years, several X-ray structures of human and murine abTCRs complexed The defining component of antigen-specific recognition with peptides bound to MHC class I molecules have by T lymphocytes with ab T cell receptors (TCRs) is been determined. Two different human abTCRs were MHC restriction. The concept of MHC restriction was identified in CD81 cytotoxic T cell clones (A6 and B7) derived from experiments which showed that virus-spe- specific for the Tax 11±19 peptide (LLFGYPVYV) of hu- cific effector T cells could only lyse virus-infected target man T cell lymphotrophic virus type-1 (HTLV-I) pre- cells that were of the same MHC haplotype as the ef- sented by HLA-A2 and were isolated from the peripheral fector T cells (Zinkernagel and Doherty, 1974). Two mod- blood of HTLV-I-infected patients (Utz et al., 1996). The els were proposed to explain the mechanism by which A6 and B7 a and b chains were individually expressed an uncharacterized TCR could be specific for both the in bacteria, then refolded and bound to soluble forms foreign antigen (e.g., virus) and self-MHC molecules: (1) of HLA-A2 complexed with the Tax peptide and crystal- ªaltered self,º in which a given MHC molecule was al- lized (Garboczi et al., 1996a, 1996b; Ding et al., 1998). A murine abTCR was obtained from a CD81 cytotoxic tered in an undefined, specific way that could be recog- T cell clone (2C) that was derived from alloimmunization nized by a single TCR; and (2) ªdual recognition,º in of H-2b mice with H-2d cells and was initially shown to which two distinct receptors independently recognized be specific for H-2Ld (Kranz et al., 1984). The 2C TCR the foreign antigen and the self-MHC molecule. Two was subsequently shown to be able to recognize the subsequent discoveries favored the altered self hypoth- self-peptide dEV8 (EQYKFYSV) derived from a mito- esis. First, MHC molecules were found to be peptide- chondrial protein presented by H-2Kb (Tallquist et al., binding molecules; each MHC molecule specifically 1996). The a and b chains of 2C were expressed together binds a restricted set of peptides derived from foreign in Drosophila melanogaster cells and were crystallized and self-proteins and presents them on cell surfaces to T alone and complexed with soluble dEV8/H-2Kb com- cells (Townsend et al., 1985; Falk et al., 1991). Moreover, plexes (Garcia et al., 1996, 1998). Another murine abTCR structural studies of peptide/MHC complexes showed was obtained by a different group from a CD81 cytotoxic that the surface of each complex was composed of T cell clone (N15) that was derived from mice immunized MHC elements and amino acid side chains of the bound with vesicular stomatitis virus (VSV) and shown to recog- peptide that protruded upward out of the MHC molecule nize the VSV8 peptide (RGYVYQGL) presented by H-2Kb binding site where they could be contacted by a TCR (Shibata et al., 1992). The a and b chains of N15 were (Fremont et al., 1992; Madden et al., 1993; Stern et al., expressed together in Chinese hamster ovary cells (Liu 1994). Second, the TCR responsible for specificity for et al., 1996) and crystallized with and without the soluble both the foreign antigen and MHC was shown to be a VSV8/H-2Kb complexes. Although the N15 TCR structure single cell surface heterodimeric protein composed of is determined to 2.8 AÊ resolution (Wang et al., 1998), the a and b chains (Hedrick et al., 1984; Yanagi et al., 1984; report of the N15/H-2Kb structure is of low resolution Yague et al., 1985; Dembic et al., 1986). The question (Teng et al., 1998). posed by these discoveries was this: how does a single abTCR embody specificity for both foreign (and self-) Orientation of abTCRs on the peptides plus the MHC? The most direct way to answer Peptide/MHC Complex this question was to determine the protein structure of Each of the Tax peptide±specific TCRs (A6 and B7) and the TCR bound to a peptide/MHC complex. the 2C TCR bind to the peptide/MHC complexes in a The abTCR is similar to an antibody Fab fragment in diagonal orientation. A similar mode of binding was ob- that it consists of two disulfide-linked chains, a and b, served in the N15 TCR/H-2Kb complex. The TCRs bind each containing a variable (V) and constant (C) domain. diagonally between the high points on the a1a2 helices Each variable domain has three complementarity-deter- of the MHC molecule (Figure 1). It appears that this mining regions (CDR1, CDR2, CDR3), with the highest alignment of TCR and MHC is necessary in order for the sequence diversity occuring in the CDR3 region (re- TCR to interact with the relatively small area of peptide viewed in Davis et al., 1998). The first three-dimensional surface that is not buried in the MHC molecule (Garboczi et al., 1996b; Ding et al., 1998). Bound to the MHC mole- cule in this way, the CDR1 loop of the a chain is posi- ³ E-mail: [email protected] and [email protected]. tioned over the N-terminal end of the peptide, and the Immunity 2 central peptide side chain that protrudes out of the MHC binding site. This feature of TCR recognition suggests that peptide side chains that are protruding from the middle of the MHC groove will be most important for TCR recognition. Second, it places the germline-encoded CDR2 loops over each of the MHC a helices, which provides a docking mechanism that will not be disrupted by the somatic diversification mechanisms that contrib- ute to CDR3 diversity. In each of the three TCR/peptide/ MHC complexes (A6, B7, and 2C), multiple atomic con- tacts exist between amino acid residues in the CDR2a or CDR2b loops and conserved amino acid residues on the a1 and a2 helices of the MHC. Since the CDR2a and CDR2b segments from different Va and Vb genes have conserved amino acid motifs (Arden, 1998), it is possible that conserved CDR2 motifs provide a com- monality which permits different V region CDR2s to bind to any class I molecule that displays its own conserved residues on the a1 and a2 helices. Such a conserved docking structure could provide an explanation for the difficulty in inducing MHC-restricted antibodies. While antibody CDR3 loops could bind to the peptide side chains that point up out of the MHC molecule, antibodies do not have the conserved sequence motifs of the CDR2 Figure 1. Side View of the Four Known TCR/MHC Orientations loops of TCR V segments and may thus have difficulty Ribbon depiction of the human A6 and B7 and the mouse 2C and docking onto the MHC molecule. N15 TCRVaVb regions oriented on their respective MHC complexes. To date, a structure has not been reported of the The VaVb domains are shown in red (Va) and in green (Vb). In blue are the helices (front, a2; back, a1) of the MHC molecules. In gray complex of a TCR and a peptide/MHC class II molecule, is the b sheet forming the floor of the MHC peptide-binding site. This so it is not yet known if this diagonal mode of TCR figure was made by superimposing (program LSQMAN [Kleywegt, interaction with peptide/MHC class I molecules will be 1996]) each MHC a1a2 domain on to the a1a2 domain of HLA- applicable to class II interactions. However, studies on A2 using coordinates deposited at the Protein Data Bank (PDB) class II±restricted TCR recognition using TCR mutagen- (accession numbers 1ao7, 1bd2, and 2ckb) and from J.-H. Wang esis (Engel and Hedrick, 1988; Katayama et al., 1995) (Teng et al., 1998) and by depicting the orientations with the program MOLSCRIPT (Kraulis, 1991). Not shown are the constant domains and TCR selection by variant peptide immunization (Jor- of the TCR and the a3 and b2m domains of the MHC molecule. gensen et al., 1992; Sant'Angelo et al., 1996) all provide indirect evidence that the use of such a diagonal binding mode will also be true for class II±restricted TCR recog- CDR1 loop of the b chain is over the C-terminal end of nition. the peptide. The CDR2 loop of the a chain is positioned over the MHC a2 helix, and the CDR2 of the b chain lies over the MHC a1 helix. The CDR3 loops of both a and TCR Interactions with Peptides b chains combine to form a central pocket that can bind In theory, the TCR could interact with any part of an a peptide residue that extends from the surface of the MHC-bound peptide that is not buried in the MHC mole- MHC molecule.
Recommended publications
  • MCB 50 Immunity and Disease Lecture Outline MHC Restriction Jan
    MCB 50 Immunity and Disease Lecture Outline MHC Restriction Jan. 31, 2001 I. Definition of self MHC restriction; MHC restriction is the requirement that APC or target cells express MHC molecules that the T cell recognizes as self in order for T cell to respond to the antigen presented by that APC or target cell. (T cells will only recognize antigens presented by their own MHC molecules.) CD8 T cells bind class I MHC which are expressed on most cells in the body. CD4 T cells bind class II MHC which are only expressed on specialized APCs. APCs primarily reside in 2 ° lymphoid tissue (lymph nodes, spleen) but can be found in most tissues. II. MHC Genetics Mouse MHC gene complex called H-2. Human MHC gene complex called HLA. MHC Molecules Mouse H-2 Human HLA Class I K,D,L A, B, C Class II I-A, I-E DR, DQ, DP Definitions: Alleles functional forms of the same genes. Heterozygous different allele at each locus. Homozygous same allele at each locus. Haplotype is the total set of MHC alleles present on one chromosome. For each MHC gene locus you have 2 copies which can be denoted by their allele classification. Most humans will be heterozygous and will have different alleles for each of the different HLA loci. (e.g. A2/A12, B17/B83, C3/C37, DR3/DR4 etc). Syngeneic identical at all MHC loci same allele on both chromosomes. (inbred mice or identical twins). Allogeneic --genetically different at MHC different alleles. Every person gets a chromosome from each biological parent which contains an MHC molecule at each locus.
    [Show full text]
  • Repertoire Selection from Data on the Mature T Cell Deriving Quantitative
    Deriving Quantitative Constraints on T Cell Selection from Data on the Mature T Cell Repertoire This information is current as Vincent Detours, Ramit Mehr and Alan S. Perelson of October 2, 2021. J Immunol 2000; 164:121-128; ; doi: 10.4049/jimmunol.164.1.121 http://www.jimmunol.org/content/164/1/121 Downloaded from References This article cites 75 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/164/1/121.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 2, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2000 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Deriving Quantitative Constraints on T Cell Selection from Data on the Mature T Cell Repertoire1 Vincent Detours,*†‡ Ramit Mehr,§ and Alan S. Perelson2* The T cell repertoire is shaped in the thymus through positive and negative selection. Thus, data about the mature repertoire may be used to infer information on how TCR generation and selection operate.
    [Show full text]
  • Thymic Nurse Cells Participate in Heterotypic
    Send Orders for Reprints to [email protected] 828 Current Molecular Medicine 2015, 15, 828-835 Thymic Nurse Cells Participate in Heterotypic Internalization and Repertoire Selection of Immature Thymocytes; Their Removal from the Thymus of Autoimmune Animals May be Important to Disease Etiology J.C. Guyden1, M. Martinez2, R.V.E. Chilukuri1, V. Reid3, F. Kelly4 and M.-O.D. Samms*,1 1Department of Biology, The City College of New York, New York, NY 10031, USA 2Department of Biology College of Arts and Sciences, Tuskegee University, Armstrong Hall, Room 107, 1200 West Montgomery Road, Tuskegee, AL 36088, USA 3The Hall Perrine Cancer Center, Department of Surgery, Mercy Medical Center Cedar Rapids, IA, Division of Surgical Oncology & Endocrine Surgery, The University of Iowa Hospitals & Clinics, 200 Hawkins Dr, Iowa City, IA 52242, USA 4Essential Health, St Mary’s Medical Center, 407 East 3rd Street, Duluth, MN 55805, USA M.-O.D. Samms Abstract: Thymic nurse cells (TNCs) are specialized epithelial cells that reside in the thymic cortex. The initial report of their discovery in 1980 showed TNCs to contain up to 200 thymocytes within specialized vacuoles in their cytoplasm. Much has been reported since that time to determine the function of this heterotypic internalization event that exists between TNCs and developing thymocytes. In this review, we discuss the literature reported that describes the internalization event and the role TNCs play during T cell development in the thymus as well as why these multicellular complexes may be important in inhibiting the development of autoimmune diseases. Keywords: Thymic nurse cells, internalization, MHC restriction, lupus erythromatosus.
    [Show full text]
  • HLA-Restricted, Processing- and Metabolism-Independent Pathway of Drug Recognition by Human Alpha Beta T Lymphocytes
    HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. M P Zanni, … , S Valitutti, W J Pichler J Clin Invest. 1998;102(8):1591-1598. https://doi.org/10.1172/JCI3544. Research Article T cell recognition of drugs is explained by the hapten-carrier model, implying covalent binding of chemically reactive drugs to carrier proteins. However, most drugs are nonreactive and their recognition by T cells is unclear. We generated T cell clones from allergic individuals specific to sulfamethoxazole, lidocaine (nonreactive drugs), and cef-triaxone (per se reactive beta-lactam antibiotic) and compared the increase of intracellular free calcium concentration ([Ca2+]i) and the kinetics of T cell receptor (TCR) downregulation of these clones by drug-specific stimulations. All drugs tested induced an MHC-restricted, dose- and antigen-presenting cell (APC)-dependent TCR downregulation on specific CD4(+) and CD8(+) T cell clones. Chemically nonreactive drugs elicited an immediate and sustained [Ca2+]i increase and a rapid TCR downregulation, but only when these drugs were added in solution to APC and clone. In contrast, the chemically reactive hapten ceftriaxone added in solution needed > 6 h to induce TCR downregulation. When APC were preincubated with ceftriaxone, a rapid downregulation of the TCR and cytokine secretion was observed, suggesting a stable presentation of a covalently modified peptide. Our data demonstrate two distinct pathways of drug presentation to activated specific T cells. The per se reactive ceftriaxone is presented after covalent binding to carrier peptides. Nonreactive drugs can be recognized by specific alphabeta+ T cells via a nonconventional presentation pathway based on a labile binding […] Find the latest version: https://jci.me/3544/pdf HLA-restricted, Processing- and Metabolism-independent Pathway of Drug Recognition by Human ab T Lymphocytes Martin P.
    [Show full text]
  • T Cell Maturation
    T-cell Maturation T cell maturation What allows T cell maturation? T cell progenitor DN DP SP 2ry • Direct contact with thymic epithelial cells (Subcapsular (Cortex) (Medulla) lymphoid zone) organs • Influence of thymic hormones THYMUS • Growth factors (cytokines, CSF) The earliest T cell precursors in the thymus : - Express Thy-1 (mice) - Have not yet rearranged TCR loci - Do NOT express CD4 or CD8 - Do not express CD3 - Are called “double negatives” MARKERS: - C-KIT - Receptor for Stem Cell Growth Factor - CD44 - Adh. Molecule. Homing to thymus - CD25 - Alpha chain of IL-2 receptor Time Course of Appearance in Thymus - Most double negative thymocytes will give rise to αβαβαβ T cells (in mice and humans). * - Some (5%) will differentiate into γδγδγδ T cells. - The developmental pathway of γδγδγδ T cells is not well defined. 1 Why is Pre-TCR important? - CD3 expression first appear between DN2 to DN3 - Double negative thymocytes (DN3 stage) undergo β chain locus re-arrangement. - The newly formed β chain combines with the Pre-Tα (surrogate chain) and CD3 to form the Pre-T cell receptor ( Pre-TCR ). 1) Productive TCR β chain re-arrangement 2) Signals for proliferation (similar β chain) and maturation 3) Suppresses further β chain re-arrangement (allelic exclusion) 4) Signals for TCR ααα chain re-arrangement 4) Induces development of CD4+8+ (double positive) stage - After β chain re-arrangement is completed the DN3 cells Positive and Negative selection of T cells: GOAL—to progress to DN4. recognize foreign Ag combined with self MHC - Both CD4 and CD8 are expressed = double positive (DP) cells.
    [Show full text]
  • T Cell Receptor
    Self-MHC restriction of the T cell Chapter 9 receptor (TCR) • Self restriction- T cell can only be activated by a unique peptide associated with self-MHC. T cell Receptor • Two models: – A) Dual receptor model : two receptors, one for the antigen and one for the MHC molecule – B) Altered self model : One receptor that recognizes both antigen and MHC molecule Self-MHC restriction of the TCR The αβαβαβ TCR is similar in size and structure to an antibody Fab fragment The αβαβαβ T cell receptor - Two chains - ααα and βββ - Two domains per chain - constant (C) domain - variable (V) domain - Chains held together by disulfide bonds - Small cytoplasmic tails on each chain Kuby Figure 9-3 Kuby Figure 9-3 1 - Some T cells express a TCR made of two alternate chains - γγγ and δδδ Table 9.1 Comparison of TCR - The γδγδγδ TCR is structurally similar αβ T cells γδγδγδ T cells to the αβαβαβ TCR. • % CD3 + 90-99% 1-10% - 0.5-15% of peripheral blood T cells • TCR V gene Large Small use the γδγδγδ TCR. A higher proportion in germline of T cells in the skin and intestinal epithelium use the γδγδγδ TCR. • CD4/CD8 60% <1% −−−γδγδγδ T cells seem to be biased CD4 toward recognition of specific CD8 30% 30% microbial antigens. CD4-CD8- <1% 60% −−−γδγδγδ T cells are thought to represent • MHC restriction Yes No a different lineage of T cells with specialized functions. • Ligands Peptide+ MHC Phospholipid antigen Intact protein Kuby Figure 9-9 (modified) TCR Receptor Complex- CD3 The TCR complex includes CD3 - 3 heterodimers: γεγεγε , εδεδεδ and ζζζζζζ - 1) TCR is not expressed without CD3.
    [Show full text]
  • MHC − Bound to Peptide the First Structures of T Cell Receptors
    The First Structures of T Cell Receptors Bound to Peptide−MHC Kai W. Wucherpfennig This information is current as J Immunol 2010; 185:6391-6393; ; of September 26, 2021. doi: 10.4049/jimmunol.1090110 http://www.jimmunol.org/content/185/11/6391 Downloaded from References This article cites 26 articles, 11 of which you can access for free at: http://www.jimmunol.org/content/185/11/6391.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 26, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The First Structures of T Cell Receptors Bound to Peptide–MHC Kai W. Wucherpfennig he structure of the MHC class I molecule HLA-A2 yielded small quantities were reported. On the MHC side, it reported in 1987 by Bjorkman et al. (1) had revealed became clear that the MHC helices actually folded around T how peptide Ags are presented to T cells: peptides are the offered peptide and that it was impossible to generate sta- buried in the long and deep groove of the MHC molecule, ble, empty MHC class I molecules that could later be loaded flanked on each side by a long a helix.
    [Show full text]
  • Hypothesis: the Mhc-Restricted T-Cell Receptor As a Structure with Two Multistate Allosteric Combining Sites*
    Molecular Immunology, Vol. 21, No. 11. pp. 1037-1046, 1984 0161-5890/84 $3.00 + 0.00 Printed in Great Britain . Pergamon Press Ltd HYPOTHESIS: THE MHC-RESTRICTED T-CELL RECEPTOR AS A STRUCTURE WITH TWO MULTISTATE ALLOSTERIC COMBINING SITES* W. LOUIS CLEVELAND and BERNARD F. ERLANGER Department of Microbiology. Columbia University Cancer Center/Institute of Cancer Research. New York, NY 10032, U.S.A. (Accepted 10 July 1984) Abstract-This paper presents a dual-recognition model of the T-cell receptor that has been constructed to account for the phenomenon of MHC restriction as well as the paradoxical ability of T-cells to be both multispecific and precisely specific at the same time. In our model the combining sites for antigen and MHC are not independent as in classical dual-recognition models. but interact with each other by an allosteric mechanism. We envision a flexible receptor with combining sites for antigen and MHC that are capable of existing in a multitude of distinct complementarity states. MHC and antigen molecules act as allosteric effectors such that one ligand perturbs the conformation and therefore the specificity of the site for the other ligand. An essential feature of the model is that different MHC determinants induce different conformations at the anti-antigen site. In this way the receptor acquires multiple specificities. Within a particular complementarity state, precise recognition results from the requirement that antigen and MHC exhibit positive cooperativity in their binding to the T-cell receptor. Positive cooperativity is also the basis for MHC restriction. Reaction mechanisms are presented which describe the requirement that antigen and MHC both induce conformational changes in order to generate high-affinity binding to either ligand.
    [Show full text]
  • The Antigenic Determinant That Defines Thymic Nurse Cells Is Expressed by Thymic Epithelial Progenitor Cells
    City University of New York (CUNY) CUNY Academic Works Publications and Research City College of New York 2014 The antigenic determinant that defines thymic nurse cells is expressed by thymic epithelial progenitor cells Rajendra V. E. Chilukuri CUNY City College Viral K. Patel CUNY City College Marcia Martinez Tuskegee University Jerry C. Guyden CUNY City College Michael D. Samms CUNY City College How does access to this work benefit ou?y Let us know! More information about this work at: https://academicworks.cuny.edu/cc_pubs/129 Discover additional works at: https://academicworks.cuny.edu This work is made publicly available by the City University of New York (CUNY). Contact: [email protected] ORIGINAL RESEARCH ARTICLE published: 28 April 2014 CELL AND DEVELOPMENTAL BIOLOGY doi: 10.3389/fcell.2014.00013 The antigenic determinant that defines thymic nurse cells is expressed by thymic epithelial progenitor cells Rajendra V. E. Chilukuri 1, Viral K. Patel 1, Marcia Martinez 2, Jerry C. Guyden 1 and Michael D. Samms 1* 1 Department of Biology, The City College of New York, New York, NY, USA 2 Biology, Tuskegee University, Tuskegee, AL, USA Edited by: Stromal thymic epithelial cells with the multicellular structure unique to thymic nurse cells Atsushi Asakura, University of (TNCs) express the pH91 antigen on their cell surfaces. The multicellular TNC-complexes Minnesota, USA develop through an intimate association between αβTCR+CD4+CD8+ thymocytes and Reviewed by: pH91-expressing cortical epithelial cells. TNCs participate in MHC-restriction and exhibit Yousuke Takahama, University of Tokushima, Japan epithelial cell progenitor characteristics. In this report, we show that as early as E11.5 Maria Guadalupe Reyes-Garcia, stage of thymus development, the pH91 antigen is expressed in association with K8, K5, National Autonomous University of Foxn1, and p63.
    [Show full text]
  • Cellular and Peptiderequirements for in Vitro Clonal Deletion of Immature
    Proc. Nati. Acad. Sci. USA Vol. 89, pp. 9000-9004, October 1992 Immunology Cellular and peptide requirements for in vitro clonal deletion of immature thymocytes KAZUYA IWABUCHI*, KEI-ICHI NAKAYAMA*, RODERICK L. McCoy*, FANPING WANG*, TAKASHI NISHIMURAt, SONOKo HABUt, KENNETH M. MURPHYt, AND DENNIS Y. LoH* Departments of *Medicine, Genetics, and Molecular Microbiology, and *Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110; and tDepartment of Immunology, Tokai University School of Medicine, Isehara 259-11, Japan Communicated by Herman N. Eisen, June 23, 1992 (receivedfor review March 16, 1992) ABSTRACT Thymocytes from DO1 T-cell-receptor deletion system that can be used to elucidate the cellular and trasgenic mice undergo apoptosis, or programmed cell death, peptide-antigen requirements for inducing clonal deletion. when chicken ovalbumin-(323-339) peptide is administered in vivo. Using DO1 mice thymocytes, we have now developed a EXPERIMENTAL PROCEDURES simple in vitro model system that recapitulates the in vivo Mice. TCR transgenic mice (DO10) bearing TCR from a clonal-deletion process. When transgenic thymocytes were hybridoma, DO11.10, with specificity for cOVA-(323-339) cocultured with fibroblasts, B cells, or thymic nurse cell lines and I-Ad have been backcrossed to BALB/c mice and are (all bearing I-Ad) in the presence of chicken ovalbumin-(323- maintained in our own animal facility. KA mice were created 339), deletion of the transgenic TCR+CD4+CD8+ thymocytes by the microinjection of I-Ad genes (a and f3) driven by class was seen within 8-20 hr. Thymocytes designed to bear I-Ad on I MHC Kb promoter into mouse embryos and maintained in their surface could mediate the deletion themselves.
    [Show full text]
  • Significance of The
    CHAPTERCHAPTER 7 7 SignificanceSignificance ofof thethe MHCMHC MajorMajor HistocompatibilityHistocompatibility Complex Complex (MHC)(MHC) WhatWhat isis MHC?MHC? rolerole inin immuneimmune responseresponse ––HLAHLA rolerole inin organorgan transplantationtransplantation – H-2 – H-2 rolerole inin predispositionpredisposition toto diseasedisease ––MinorMinor histocompatibilityhistocompatibility antigensantigens ––PeterPeter GorerGorer & & GeorgeGeorge SneellSneell (1940) (1940) - MHC molecules were initially discovered during studies Chromosome 17 aimed at understanding the molecules responsible for rejection of transplanted tissues . - Hence the name “Major Histocompatibility Complex ” L (MHC). - The term “Major Histocompatibility Complex” actually refers to a region of the genome that encodes a number of genes (hence Complex) that play an important (hence Chromosome 6 Major) role in tissue transplantation (hence Histocompatibility). - The term “MHC molecule” or “MHC antigen” refers to a molecule encoded by a gene within this region. In humans: In the Mouse: Class I = A, B and C (also called HLA-A, HLA-B and HLA-C) Class I = K, D and L molecules (also called - Ag (peptide) presentation to CD8+ cells H-2D, H-2K and H-2L) Class II = DP, DQ and DR (also called Class II = A and E (also called I-A and I-E) HLA-DP, HLA-DQ and HLA-DR) - Ag (peptide) presentation to CD4+ cells Class III = Complement proteins, Tumor necrosis factor (TNFs)-α, β Class III = Complement proteins, Tumor necrosis factor (TNFs)-α, β 1 MHC- Polimorphism PolymorphismPolymorphism
    [Show full text]
  • The Major Histocompatibility Complex, MHC
    The Major Histocompatibility Complex, MHC Ning Pan Department of Pathogen biology and Immunology Medical School , Southeast University 1 2 • George Snell (1903-1996) discovered the first components of the MHC through their role in rejecting transplants in mice, and created the word “histocompatibility”. • Around a decade later, Jean Dausset (1916-2009) uncovered the first compatibility antigen in humans. • Experiments by Baruj Benacerraf (1920-2011) in the 1970s provided the first indication that immune reactions are controlled by the MHC genes ('immune response genes' ). 3 • T cells do not recognize intact antigen (the whole chicken) • Interact only with antigen fragments — peptide (the drumstick) • Peptides are only recognized when they are associated with self-MHC molecules (presented by a waiter) 4 Terminology 1 • Histocompatible: transplanted tissue is successfully accepted as self • Histocompatibility antigens: rejection of foreign tissue is the result of an immune response to cell-surface molecules • Histocompatibility complex : a region of multiple loci that play major roles in determining whether transplanted tissue is with histocompatibility or inhistoincompatibility 5 Terminology 2 • Major vs minor – Major Histocompatibility Complex, MHC : rapid graft rejection – Minor Histocompatibility complex, mHC : slow graft rejection • HLA: human leukocyte antigen, MHC antigens in human • H-2: MHC antigen in mice 6 Terminology 3 • HLA or MHC gene/complex — DNA • HLA or MHC antigen/molecule — protein 7 HLA complex 8 HLA complex spans 3.5
    [Show full text]